Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse.

Autor: Antić Ž; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Yu J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Bornhauser BC; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Lelieveld SH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Ham CG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van Reijmersdal SV; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Morgado L; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Elitzur S; Pediatric Hematology-Oncology, Schneider Children's Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Bourquin JP; Department of Oncology and Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland., Cazzaniga G; Centro Ricerca Tettamanti, Fondazione Tettamanti, University of Milan Bicocca, Monza, Italy., Eckert C; Pediatric Oncology/Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Camós M; Leukemia and Other Pediatric Hemopathies, Developmental Tumor Biology Group, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Hematology Laboratory, Hospital Sant Joan de Deu Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Sutton R; Molecular Diagnostics, Children's Cancer Institute, University of New South Wales, Sydney, New South Wales, Australia., Cavé H; Department of Genetics, Robert Debré Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; INSERM U1131, Saint-Louis Research Institute, University of Paris, Paris, France., Moorman AV; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK., Sonneveld E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group, Utrecht, The Netherlands., Geurts van Kessel A; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., van Leeuwen FN; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hoogerbrugge PM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group, Utrecht, The Netherlands., Waanders E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Jan; Vol. 69 (1), pp. e29361. Date of Electronic Publication: 2021 Oct 01.